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ABSTRACT 
Over the last years Candida species, including Candida 
albicans, Candida dubliniensis, Candida glabrata, 
Candida krusei, Candida parapsilosis, and Candida 
tropicalis, have emerged as significant pathogens. This 
work aimed at bringing insights into Candida species 
world by the analyses of compounds released into the 
extracellular medium namely extracellular DNA 
(eDNA) and alcohol compounds. Concerning eDNA, 
our results present evidence that this is a key element 
of the C. albicans biofilm extracellular matrix, 
contributing to biofilm integrity and antifungal 
resistance. With respect to extracellular alcohols, the 
results presented herein show that Candida species 
secrete a cohort of alcohols that are able to regulate 
their virulence traits (in vitro and in vivo). Taken 
together, these studies represent an important 
contribution to our understanding of the composition of 
the extracellular milieu of Candida species and its 
relationship with the regulation of Candida biology, 
opening the possibility of the development of new 
treatment and/ or diagnostic strategies to combat 
candidiasis. 
 
INTRODUCTION 
Starting in the early 1980s, fungal diseases began to 
constitute a major public health problem. The observed 
increase in opportunistic fungal infections has parallel 
with the expansion in populations with metabolic and 
immunosuppressive diseases, and mucosal or 
cutaneous barrier disruption, as a consequence of the 
advances in medical practices (Hazen, 1995;Pfaller and 
Diekema, 2007). Overall, Candida species are now 
recognized as major agents of opportunistic fungal 
infections worldwide. Although for many years 
Candida infections were synonymous of diseases 
caused by Candida albicans, the most recent 
surveillance studies indicate that Non-Candida 
albicans Candida (NCAC) species, particularly, 
Candida dubliniensis, Candida glabrata, Candida 
krusei, Candida parapsilosis, and Candida tropicalis 
are emerging as pathogens (Lewis, 2009;Pfaller and 
Diekema, 2007;Loreto et al., 2010). This species 
distribution shift has been attributed to NCAC species 
intrinsic or acquired resistance to antifungal agents, 
namely fluconazole (Lewis, 2009). The recognition of 
Candida infections as a life-threatening problem 
associated with high mortality rates and costs, due to 
increased length of patients hospitalization, antifungals 
acquisition, ineffective treatment, and antifungals side 
effects (Hennen, 2009), probably are responsible for 
the increasingly interest in the study of Candida and 
candidiasis.  
Candida species live in complex and dynamic 
environments, being consequently exposed to external 
cues. In fact, to colonize so diverse niches such as the 
skin, gastrointestinal tract, or oral cavity, the cells need 
to adapt, for example, to different pH and oxygen 
levels, and microbial flora. This plasticity may involve 
the sensing of multiple environmental inputs and 
adaptation/ response through the expression of 
virulence factors. Candida species virulence factors 
comprise the ability of C. albicans and C. dubliniensis 
to undergo a morphological transition between yeast 
and filaments (pseudohyphae and/or hyphae), the 
ability of Candida species to form biofilms, and to 
release molecules into the extracellular medium 
including proteins and alcohols such as E,E-farnesol 
(farnesol) (Calderone and Fonzi, 2001;Li et al., 
2007;Haynes, 2001;Trofa et al., 2008;Sullivan et al., 
2005;Samaranayake and Samaranayake, 
1994;Langford et al., 2009). Therefore, one of the 
challenges in fundamental research is to identify the 
components that mediate these interactions and to 
understand their effect and strength on cell phenotype, 
to ultimately develop functional models that may help 
to get a better understanding on cellular biology and 
pathogenesis (Sauer et al., 2007).  
In the last decade it was observed an increase in the 
“omics” approaches in the Candida field, crucial to the 
elucidation of the fungal biological and physiological 
responses to its environment. The genomic era started 
with C. albicans (Jones et al., 2004) and C. glabrata 
(Dujon et al., 2004) genomes sequence, but only 
recently C. dubliniensis (Jackson et al., 2009), C. 
parapsilosis, C. tropicalis, Candida guilliermondii, and 
C. lusitaniae (Butler et al., 2009), but not C. krusei 
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genome sequences were published. The initial genomic 
studies in C. albicans opened the possibility to perform 
transcriptomic studies that, by measuring the dynamic 
expression of messenger RNA (mRNA), have been 
used to identify genes relevant to physiological 
processes, as dimorphism (Nantel et al., 2002) or in 
particular niches, such as biofilms [reviewed by 
Coenye (2010)]. Moreover, the proteomic studies, 
through the analysis of global patterns of protein 
expression, have been applied to the identification of 
key proteins related for example with cell adhesion or 
drug resistance [reviewed by Thomas et al. (2006)]. 
Overall, the combination of these approaches has been 
helpful to get a better understanding on C. albicans 
existence as a human commensal and pathogen. 
However, the cells adjust their metabolism, and 
consequently their metabolites, according to the 
different physiological states (Oldiges et al., 2007). 
The whole group of metabolites -the metabolome- link 
DNA, mRNA, proteins, complex interactions, and 
cellular pathways with environmental stimuli, thus 
being considered functional entities of the cells (Zhang 
et al., 2010;Jewett et al., 2006). Metabolomic -the 
quantification of the metabolome- or metabolic 
profiling -the quantification of a set of pre-defined 
metabolites belonging to a class of compounds or to 
members of particular pathways- (Oldiges et al., 2007) 
are unexploited topics in the Candida field. However, 
increased awareness is arising in the scientific 
community, with the “Biochemical Pathways” feature 
being recently added as a tool at the Candida Genome 
Database (CGD, http://www.candidagenome.org/) 
(Skrzypek et al., 2010).  
Due to the diversity of fungal extracellular metabolites 
(Frisvad et al., 2007) and their dynamic regulation, the 
complete analysis of the metabolome is considered a 
difficult task (Villas-Boas et al., 2005). Even though, it 
is possible to perform target analysis for the detection 
and quantification of a single or a small set of 
metabolites (Oldiges et al., 2007), thus achieving 
partial insights into the metabolome.  
Thus, this work aimed at bringing insights into 
Candida species world, through the evaluation of 
compounds released into the extracellular medium, 
namely extracellular DNA (eDNA) and alcohol 
compounds, and the elucidation of the interactions of 
the identified molecules with virulence traits of 
Candida species.  
 
EXTRACELLULAR DNA 
The interest on the study of C. albicans eDNA was 
raised by evidences showing that: (i) eDNA 
accumulates into the extracellular medium in vitro and 
in vivo (Kasai et al., 2006), (ii) eDNA can regulate the 
host immune response (Yordanov et al., 
2005;Dimitrova et al., 2008;Miyazato et al., 2009), and 
(iii) deoxyribonuclease (DNase) reduces mature 
biofilm biomass (Al-Fattani and Douglas, 2006). Even 
though, this molecule has not received considerable 
attention in the Candida biofilm field, and it has not 
been addressed, for example, whether it is a component 
of biofilm extracellular matrix (ECM) or not, or further 
exploited regarding its contribution to biofilm lifestyle. 
Using a fluorometric method, we were able to detect 
the accumulation of eDNA in the ECM extracted from 
C. albicans biofilms formed under conditions of flow, 
although the quantity of eDNA detected differed 
according to growth conditions, in particular with 
regards to the medium used to grow the biofilms (Table 
1) (Martins et al., 2010b).  
 
Table 1: C. albicans 48-h biofilm ECM eDNA and 
protein content 
 
 
One of the points under debate in the Candida 
scientific community relates to the origin of C. 
albicans eDNA. Accumulated evidences in the 
bacterial field suggest that eDNA may be released 
through quorum sensing, by specific secretion 
mechanisms, and cell lysis (Draghi and Turner, 
2006;Spoering and Gilmore, 2006). The most accepted 
hypothesis in the Candida field is that fungal eDNA is 
a by-product derived from cell lysis within the biofilm 
(personal communications on international 
conferences). Our preliminary studies on the evaluation 
of the eDNA electrophoretic mobility in conventional 
agarose gels containing ethidium bromide showed that 
eDNA is not similar to genomic DNA, exhibiting a 
smear profile (ranging approximately from 5000 to 75 
bp) (unpublished data). This suggests that C. albicans 
eDNA is derived from cell death (van, V and Pretorius, 
2008). However, research is still needed: (i) to 
establish a possible correlation between cell death 
(necrosis and/or apoptosis), eDNA release, and biofilm 
formation, and (ii) to exploit other origin(s) of eDNA. 
In addition, the role of eDNA was addressed in terms 
of biofilm development and antifungal susceptibility. 
First, C. albicans biofilms were formed using a 
microtiter plate model (Pierce et al., 2008) and the 
effect of eDNA degradation by DNase and addition of 
exogenous DNA at different stages of biofilm 
development was evaluated. These experiments 
indicated that at later stages of biofilm development: (i) 
DNase treatment (> 0.03 mg/ml) decreases biofilm 
biomass (Figure 1A) in comparison with non-treated 
Growth medium eDNA Protein eDNA/ protein 
 (ng) (mg) (ng/mg) 
RPMI 1518 ± 822 0.48 ± 0.2 3045.4 ± 227.3 
YPD 180 ± 160 0.42 ± 0.1 339.6 ± 265.6 
YNB 1.8 ± 1.6 0.10 ±0.1 13.0 ± 8.8 
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biofilms (Figure 1B), and (ii) addition of exogenous 
DNA (>160 ng/ml) increases biofilm biomass (data not 
shown). This suggests that eDNA contributes to the 
maintenance and stability of mature biofilms, but not to 
their establishment (Martins et al., 2010b).  
 
 
Figure 1: Example of microscopy evaluation of 24-h C. 
albicans biofilms treated with DNase 0.13 mg/ml (A), 
in comparison with non-treated controls (B). 
 
One of the aspects that may be further exploited relates 
to the existence and/or role of eDNA derived from 
biofilm cells but not embedded within the ECM. In 
fact, it is possible that a portion of the eDNA released 
by biofilm cells is not trapped by the ECM, being 
released to the surrounding environment. It may be 
interesting to address: (i) how circulating eDNA 
derived from biofilm cells circulates, since it is known 
that proteins are able to bind DNA (Tamkovich et al., 
2008), and (ii) the role of biofilm eDNA in the 
modulation of the host immune system. A step forward 
in the research on eDNA in Candida species, is the 
evaluation of the potential use of eDNA as a marker for 
the diagnostic and/or prognostic of Candida infections, 
similarly to the observed for other Candida 
extracellular components such as β-1,3-glucans 
(Montagna et al., 2009).  
Second, our investigations showed a novel role for 
eDNA in C. albicans biofilms, as a regulator of 
antifungal susceptibility. Results in Figure 2 show that 
mature biofilm cells treated with DNase and one 
polyene drug -amphotericin B- (Figure 2A) or one 
echinocandin agent -caspofungin- (Figure 2B) and 
exhibited lower % of 2,3-bis(2-methoxy-4-nitro-5-
sulfophenyl)-5-[(phenylamino)carbonyl]-2H-
tetrazolium hydroxide (XTT) colorimetric readings in 
comparison with those treated with antifungal drug 
only. Contrary to the observed for these antifungals, 
the susceptibility of C. albicans biofilm cells against 
the azole drug fluconazole was not changed by the 
addition of DNase (data not shown). These results 
suggest that DNase increases the effectiveness of these 
drugs against C. albicans biofilms. This is particularly 
relevant considering biofilm cells increased antifungal 
resistance in comparison with planktonic counterparts 
(Chandra et al., 2001). Notably, in the last years the 
combined use of drugs (Espinel-Ingroff, 2009) or drugs 
with agents such as enzymes (Kaplan, 2009), has 
received considerable attention. Advantages of the use 
of ECM degrading enzymes include their broad 
spectrum activity, being unlikely the development of 
antimicrobial resistance, and their use as therapeutic 
agents (e.g. DNase is already used for cystic fibrosis 
treatment), suggesting that they may be well tolerated 
and active when used in a clinical setting. However, it 
may not be ignored that enzyme-based therapies are 
expensive and may increase the risk of distal sites 
colonization due to biofilm dispersion (Kaplan, 2009).  
 
 
Figure 2: Activity of amphotericin B (A) and 
caspofungin (B) used alone (white bars) or in 
combination with DNase 0.13 mg/ml (grey bars) 
against C. albicans 24-h biofilms.  
 
Even though, the potential therapeutic use of ECM 
degrading enzymes is not a new issue in the Candida 
field, since the enhanced efficacy of the combined use 
of β-1,3-glucanase and antifungal agents in the 
eradication of C. albicans biofilms has been previously 
shown by Nett el al. (2007). This corroborates our 
observations that agents that target processes affecting 
the biofilm structural integrity may have potential use 
as therapeutic adjuvants in biofilm treatment, at least as 
part of antifungal lock-like therapy of devices. 
Nevertheless, the potential relevance of our findings, 
requires further in vitro experiments in order: (i) to 
understand whether the reduced levels of mitochondrial 
cell activity (% XTT colorimetric readings) represent 
an effective reduction in metabolism or are resultant of 
cell dispersion, (ii) to determine the fractional 
inhibitory concentration index, as a measure of synergy 
between DNase and these antifungal agents, and (iii) 
the evaluation of more drugs from each antifungal 
class. Furthermore, for the consideration of DNase as 
an anti-candidal enzyme, it is necessary to evaluate 
eDNA presence and function on an additional number 
of C. albicans strains and other Candida species.  
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Overall, the results of this set of experiments show that 
eDNA is a component of C. albicans biofilm ECM that 
contributes to biofilm integrity and antifungal 
resistance. Introducing a new line of research, these 
studies expanded the current knowledge on C. albicans 
biofilm ECM. 
 
EXTRACELLULAR ALCOHOLS 
The second set of molecules selected in our studies 
comprised extracellular alcohols. These were pointed 
as targets for our research due to: (i) the recent 
discovery of the extracellular alcohol farnesol as a 
quorum sensing molecule in C. albicans (Hornby et al., 
2001), and (ii) sparse studies suggesting that fungal 
cells release autoregulatory molecules into the 
extracellular medium, such as fatty acids (Noverr et al., 
2003) or aromatic alcohols (e.g., tyrosol) (Chen et al., 
2004). As observed in other Candida research areas, 
the investigation on NCAC species is scarce, and for 
example not much is known on the role of farnesol in 
NCAC species. In addition, the identification of 
extracellular alcohols released by C. albicans, and 
NCAC species, is dependent on appropriate analytical 
methods. Overcoming this constraint will open the 
possibility of exploiting the interaction of the identified 
molecules with virulence traits of Candida species.  
Previous investigations on the effect of farnesol on 
NCAC species planktonic cells suggested a species 
dependent response: (i) in C. dubliniensis, dimorphism 
control, without growth changes (Henriques et al., 
2007), and (ii) in C. parapsilosis, growth regulation 
(Rossignol et al., 2007). Thus we aimed at examining 
the effect of the addition of exogenous farnesol in other 
NCAC species planktonic cells. Therefore, the effect of 
farnesol (5 to 150 µM) in C. glabrata, C. krusei, and C. 
tropicalis planktonic cells was evaluated using a set of 
methodologies, that included morphology, growth 
(Henriques et al., 2007) and viability (Coder, 1997) 
monitoring, and DNA profiling for cell cycle 
evaluation (Fortuna et al., 2000). Farnesol did not 
induce morphological changes in the assayed NCAC 
species (data not shown). As exemplified in Figure 3 
for farnesol 100 µM treatment, this alcohol affects C. 
glabrata (Figure 3A), C. krusei (Figure 3B), and C. 
tropicalis (Figure 3C) growth. Specifically, farnesol 
(100 and 150 µM) compromised C. glabrata growth, 
which was not associated with changes in cell survival, 
although S-G2/M cell cycle phase transition was 
delayed; (ii) farnesol (50, 100, and 150 µM) delayed C. 
krusei growth without compromising cell viability, but 
delaying G0/G1 cell cycle phase; (iii) farnesol 100 and 
150 µM delayed C. tropicalis growth, that was 
associated with a decrease in cell viability and G0/G1 
phase cell cycle phase delay. Notably, very recently, an 
independent group reported the growth inhibitory 
effect of farnesol on NCAC species (Weber et al., 
2010), although the cytotoxic process was not assessed, 
contrarily to the evaluation performed in our study. 
Despite the considerable insights given by our work 
into the role of farnesol in NCAC species two main 
questions remain unanswered: first, the existence of 
farnesol receptors, and second, the potential farnesol 
targets inside Candida cells. As noted earlier, only 
recently the NCAC species genome sequences were 
available. From now on, it will be possible to develop 
for example oligonucleotide microarrays, required for 
the analysis of global pattern gene expression of 
NCAC species, for example, under the exposure to 
farnesol. 
 
 
 
 
Figure 3: Effect of farnesol on C. glabrata (A), C. 
krusei (B), and C. tropicalis (C) growth. 
 
Although the regulation of farnesol production by 
Candida species is still under debate, the farnesol 
levels considered physiologically relevant are below 50 
µM (Langford et al., 2009). It should be noted that 
physiological farnesol levels do not affect C. glabrata, 
C. krusei, and C. tropicalis growth, but they regulate C. 
albicans and C. dubliniensis morphology. This 
suggests that farnesol acts more likely as a quorum 
sensing molecule in C. albicans and C. dubliniensis, 
regulating a specific virulence trait of these Candida 
species (Sullivan et al., 2005;Calderone and Fonzi, 
2001), than in the other Candida species.  
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In addition, ongoing research in our lab suggests that 
C. albicans releases into the extracellular medium 
other molecules that differentially regulate NCAC 
species growth. Specifically, C. albicans supernatant: 
(i) does not exhibit major effects on C. glabrata and C. 
dubliniensis growth, (ii) promotes C. krusei and C. 
parapsilosis cell growth, as indicated by the higher 
levels of absorbance at 620 nm readings compared with 
control cells, but (iii) has a growth inhibitory effect on 
C. tropicalis (unpublished data). Moreover, we have 
reported that C. albicans and C. dubliniensis 
supernatants are able to regulate their own morphology 
(Martins et al., 2007). These findings prompted our 
research to the characterization of the molecules 
present in the extracellular medium and the evaluation 
of their effect.  
Using headspace solid-phase microextraction, a 
microextraction technique based in an equilibrium 
partition of the compounds between the sample matrix 
and a polymer-coated fused fiber that can be directly 
coupled with gas chromatography-mass spectrometer 
(Arthur and Pawliszyn, 1990), it was established, for 
the first time, the profile of multiple extracellular 
alcohols in Candida species (Martins et al., 
2007;Martins et al., 2010a). Therefore, in an unified 
and detailed study along time (from 24 to 96 h), a 
group of extracellular alcohols- isoamyl alcohol, 2-
phenylethanol (phenylethanol), 1-dodecanol 
(dodecanol), E-nerolidol (nerolidol), and farnesol were 
identified and quantified in planktonic and biofilm 
supernatants of C. albicans and C. dubliniensis (Table 
2). In these samples, dodecanol was found in trace 
quantities (Martins et al., 2007). Although along time 
the alcohols secretion profiles were species and culture 
mode (planktonic vs biofilm) specific (Table 2), it was 
not possible to establish a biofilm fingerprint 
concerning these alcohols identity. Thus, as an initial 
approach to get insights into extracellular alcohols 
produced by other Candida species, only planktonic 
supernatants were analyzed using the same 
methodology. These studies showed that C. 
parapsilosis and C. tropicalis 24-h supernatants 
contained farnesol, isoamyl alcohol, phenylethanol, 
and dodecanol, but not nerolidol (Martins et al., 
2010a).  
It has been suggested that the majority of the molecules 
secreted by microorganisms are able to modulate 
physiological functions, although the observed effects 
are not always derived from a quorum sensing circuit 
but many times resultant from processes of compound 
metabolisation or detoxification (Winzer et al., 2002). 
It is interesting to note that the identified extracellular 
alcohols have a volatile nature, which may help the 
signal diffusion, communication between cells, and 
regulation of virulence factors. To get insights into the 
interaction of the identified extracellular alcohols with 
virulence traits of Candida species, the effect of the 
addition of commercial formulations of the identified 
alcohols, at physiological and/or supraphysiological 
concentrations [using as reference the C. albicans and 
C. dubliniensis produced levels (Martins et al., 2007)], 
was examined in terms of Candida species 
morphogenesis, growth regulation (Martins et al., 
2007), biofilm formation (Martins et al., 2010a), and in 
the progression of disseminated candidiasis. 
First, from our studies on the effect of C. albicans and 
C. dubliniensis extracellular alcohols in their 
planktonic cells morphology (Martins et al., 2007), it 
was found that under filamentation inducing 
conditions, these compounds inhibit the yeast to 
filamentous form conversion (Table 3), calculated as 
the number of hyphae or pseudohyphae in the presence 
(HPpresA) and absence of each alcohol (HPabsA) (% 
inhibition= [(HPabsA – HppresA)/ HPabsA]*100). For 
the indicated alcohol levels C. albicans and C. 
dubliniensis growth was not affected (data not shown). 
These findings added isoamyl alcohol, phenylethanol, 
dodecanol, and nerolidol as Candida species secreted 
substances involved in the morphogenesis regulation. 
Although the intracellular targets of farnesol in C. 
albicans began to be dissected [reviewed by (Langford 
et al., 2009)] the intracellular targets of isoamyl 
alcohol, phenylethanol, and nerolidol are not known. 
To elucidate this issue, and in a first approach, the 
evaluation of the expression of genes involved in key 
pathways of morphogenesis (Biswas et al., 2007) may 
be performed. Furthermore, the knowledge on C. 
dubliniensis filamentation regulation by extracellular 
alcohols is even scarcer than in C. albicans. Thus, it   
 
Table 2: Concentration of extracellular alcohols in C. albicans and C. dubliniensis planktonic and biofilm supernatants 
 
 Alcohol Planktonic culture  Biofilm culture 
  Culture time (h)  Culture time (h) 
  24 48 72 96  24 48 72 96 
C. albicans Isoamyl alcohol (µmol/g cell dry weight) 64.09 58.23 59.36 57.91  12.94 45.17 72.49 46.12 
Phenylethanol (µmol/g cell dry weight) 7.37 18.44 24.62 43.22  5.29 29.39 37.12 88.77 
Nerolidol (nmol/g cell dry weight) 0.70 2.42 2.03 1.96  0.46 2.94 7.53 8.80 
Farnesol (nmol/g cell dry weight) 0.02 0.59 0.25 11.08  0.02 0.16 0.50 5.08 
C. dubliniensis Isoamyl alcohol (µmol/g cell dry weight) 68.79 42.15 20.00 32.90  15.32 25.90 22.70 37.99 
 Phenylethanol (µmol/g cell dry weight) 15.40 14.35 19.57 25.80  7.26 41.87 31.46 67.13 
 Nerolidol (nmol/g cell dry weight) 0.74 2.29 0.79 0.64  1.30 3.07 4.09 3.80 
 Farnesol (nmol/g cell dry weight) 0.07 2.13 0.20 0.84  0.15 1.59 0.65 1.05 
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may be particularly interesting to elucidate these 
pathways, since it has been suggested that the 
dimorphism regulation may differ between C. albicans 
and C. dubliniensis (Sullivan et al., 2005).  
 
Table 3: Effect of secreted alcohols on the 
filamentation inhibition of planktonic C. albicans and 
C. dubliniensis 
 
 
Second, we screened these compounds for their ability 
to regulate C. albicans, C. dubliniensis, C. 
parapsilosis, and C. tropicalis sessile cells evaluating 
the effect of the individual addition of the alcohols 
after 3 h of adhesion and 48 h of biofilm formation. 
After 24 h, biofilms were analyzed in terms of cellular 
mitochondrial activity (XTT assay) and total biomass 
(crystal violet assay). It was found that (i) isoamyl 
alcohol elicited antibiofilm activity against C. albicans 
and C. dubliniensis, and a heterogeneous activity 
against C. tropicalis biofilm cells, (ii) phenylethanol 
showed antibiofilm activity against C. tropicalis, (iii) 
dodecanol elicited a probiofilm activity in C. 
parapsilosis but antibiofilm activity in C. tropicalis, 
(iv) nerolidol showed an antibiofilm activity against C. 
parapsilosis and C. tropicalis, and (v) farnesol reduced 
C. albicans and C. dubliniensis biofilm (Martins et al., 
2010a). These results show for the first time, that other 
alcohol compounds, besides farnesol, regulate C. 
albicans, C. dubliniensis, C. parapsilosis, and C. 
tropicalis biofilm development. Concerning the effect 
of the evaluated alcohols on biofilm development, 
further studies are still required to evaluate: (i) the 
production of the different extracellular alcohols by C. 
parapsilosis and C. tropicalis biofilm cells, (ii) the 
impact of increasing the range of concentrations tested 
when these alcohols showed an effect, and (iii) other 
parameters such as biofilm cells morphology, and 
ECM composition, including eDNA. In addition, it 
would be interesting to elucidate how the cells in 
different regions of the biofilm respond to the addition 
of the alcohols. This can now be accomplished by 
cryosectioning the biofilms and using capture 
microdissection microscopy coupled with multiplex 
quantitative real-time reverse transcriptase polymerase 
chain reaction (Lenz et al., 2008). 
Third, as these alcohols were not individually 
identified in the supernatant, they may not act isolated 
but rather as part of a network. To further elucidate the 
biological relevance of these alcohols, C. albicans and 
C. dubliniensis 96-h planktonic and biofilm 
supernatants were mimicked using synthetic mixtures 
(cocktail solutions) containing commercial 
formulations of isoamyl alcohol, phenylethanol, 
nerolidol, and farnesol at the concentrations determined 
(Martins et al., 2007). In general, the in vitro effect of 
the cocktail mixtures, on C. albicans (Figure 4) and C. 
dubliniensis (data not shown) filamentation inhibition 
was similar to that of the corresponding supernatants. 
The exception was the cocktail solution mimicking C. 
dubliniensis planktonic supernatant (Figure 4, 
condition 3), suggesting that other morpho-regulatory 
molecules may be present in these fractions.  
 
 
 
1- C. albicans planktonic 
supernatant 
2- C. albicans biofilm 
supernatant 
3- C. dubliniensis 
planktonic supernatant 
4- C. dubliniensis biofilm 
supernatant 
 
Figure 4: Effect of 96-h supernatants (dark grey bars) 
and corresponding cocktail solutions (light grey bars) 
on the morphology of 12-h planktonic cells of C. 
albicans. 
 
In addition, an indication of the in vivo relevance of 
these alcohols was shown during infection in a well 
established murine model of hematogenously 
disseminated candidiasis (Clancy et al., 2009). At the 
time of infection, mice were injected intraperitoneally 
with the Cocktail solution simulating the composition 
of alcohols present in a C. albicans culture supernatant 
(1 ml; 94 µM isoamyl alcohol, 70 µM phenylethanol, 
3.2 nM nerolidol and 18 nM farnesol). This study 
showed an increased survival (Figure 5) and decreased 
kidney fungal burdens (data not shown) for that 
Cocktail treated mice vs control ones (injected with 
Vehicle only). In addition, histological observations 
suggested that the Cocktail, to some extent, has an 
inhibitory effect on cell proliferation and filamentation 
within the tissues (data not shown). It is still to explore 
how the Cocktail solution interferes with the host 
immune response, thus modulating the disease 
progression. This could be achieved by profiling 
cytokines with systems such as the Bio-Plex®, that 
allow the simultaneously quantification of several 
mouse cytokines. In addition, it would be interesting to 
elucidate the contribution of each individual alcohol in 
the progression of the disseminated disease. Moreover, 
evidences in literature suggest that the role of farnesol 
in vivo depends on the disease model (Navarathna et 
Alcohol  C. albicans C. dubliniensis 
 Concentration % Hyphae  
inhibition 
% Pseudohyphae 
inhibition 
Isoamyl alcohol 23 mM 95.8 ± 3.0 92.4 ± 2.1 
 46 µM 68.4 ± 12.3 70.7 ± 15.6 
Phenylethanol 500 µM 95.3 ± 1.23 91.5 ± 10.7 
 5 µM 71.4 ± 15.7 72.9 ± 17.0 
Dodecanol 2 µM 69.9 ± 16.8 74.5 ± 9.6 
 2 nM 57.8 ± 14.3 54.1 ± 12.1 
Nerolidol 1.5 µM 64.8 ± 4.7 64.6 ± 7.8 
 1.5 nM 51.1 ± 9.3 68.3 ± 5.0 
Farnesol 1.5 µM 67.5 ± 10.1 74.1 ± 17.8 
 1.5 nM 63.5 ± 10.8 57.8 ± 4.8 
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al., 2007;Hisajima et al., 2008). In light of our findings 
it would be of interest: (i) to test the effect of the 
Cocktail solution in the recently developed animal 
biofilm models (Ricicova et al., 2009;Lazzell et al., 
2009), and (ii) to ascertain the in vivo distribution and 
metabolism of these compounds, which can be 
achieved by the use of emerging imaging techniques 
such as mass spectrometry imaging (Sugiura and 
Setou, 2010). 
 
 
Figure 5: Effect of the administration of Candida 
albicans autoregulatory alcohols on mice survival. 
 
Although these studies began to dissect the regulation 
of Candida species biology through autoregulatory 
molecules, there are additional points that could be 
addressed throughout, such as: (i) the elucidation of the 
metabolic pathways underlying the production of these 
compounds, for example by the use of 13C nuclear 
magnetic resonance spectroscopy, as previously 
performed for S. cerevisiae (Dickinson, 2008), (ii) the 
study of the physiological conditions that regulate the 
production of the these alcohols in the planktonic and 
biofilm lifestyle, (iii) how the externally added 
compounds are metabolized by the cells, (iv) the 
evaluation of the effect of the alcohols on other 
virulence attributes, as adhesins, proteolytic and 
hydrolytic enzymes secretion (Trofa et al., 
2008;Calderone and Fonzi, 2001;Fidel, Jr. et al., 
1999;Sullivan et al., 2005), and (v) the evaluation of an 
higher number of strains of each Candida species. 
Overall, the results of this set of experiments report 
that other alcohol molecules, besides farnesol are 
produced by Candida species, and that these molecules 
are able to modulate filamentation, biofilm 
development, and disease pathogenesis, depending on 
the alcohol and on the Candida species. In short term, 
these findings increased our current understanding on 
the regulation of physiology and virulence traits of 
Candida species through the secretion of molecules.  
However, it cannot be disregarded that in a natural 
environment, the signal molecules may be washed out 
and the concentration of the compounds is a balance 
between their production, degradation or half-life time 
(Horswill et al., 2007) and site of colonization/ 
infection. So, one of the major challenges in the future 
is to be able to distinguish the differential production of 
molecules by the different species in different 
environments, in order to establish the comprehensive 
and accurate dynamic changes of molecules within a 
cell, which can only be achieved by the use of 
modeling tools (Zhang et al., 2010). 
 
CONCLUSIONS 
In summary, the information resulting from this thesis 
contributes to a better understanding of the 
extracellular milieu, not only of C. albicans but also of 
NCAC species. In short term, we increased our 
knowledge on specific components of Candida species 
extracellular medium- eDNA and alcohol compounds- 
and on their interaction with Candida species 
phenotype. In long term, the insights achieved can 
open the doors to other investigations that can lead to 
the development of treatment and/ or diagnostic 
strategies to combat disseminated candidiasis. 
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